Understanding the mechanisms behind muscle cell dysfunction in Myotonic Dystrophy Type 1
Identification of components and mechanisms regulating expanded CUG-repeat RNP complexes in Myotonic Dystrophy Type 1 muscle cells
This study is looking at how certain changes in muscle cells affect people with Myotonic Dystrophy Type 1, and it hopes to find new ways to help improve muscle function for those living with the condition.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10810789 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms that lead to muscle cell dysfunction in individuals with Myotonic Dystrophy Type 1 (DM1). It focuses on the role of expanded CUG-repeat RNA and its associated protein complexes in skeletal muscle cells. By using advanced techniques to identify the components of these complexes, the study aims to uncover how they contribute to the disease's progression. The findings could pave the way for new therapeutic strategies to improve muscle function in affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with Myotonic Dystrophy Type 1 who are experiencing muscle weakness or dysfunction.
Not a fit: Patients with other forms of muscular dystrophy or those without a diagnosis of Myotonic Dystrophy Type 1 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments that improve muscle function and quality of life for patients with Myotonic Dystrophy Type 1.
How similar studies have performed: Previous research has shown promise in targeting RNA-related mechanisms in muscular dystrophies, indicating potential for success in this novel approach.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Cooper, Thomas a — Baylor College of Medicine
- Study coordinator: Cooper, Thomas a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.